Ignite Creation Date:
2024-05-05 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00369512
Status:
COMPLETED
Last Update Posted:
2017-05-30
First Post:
2006-08-24
Brief Title:
A Trial of Erlotinib Radiotherapy for Cutaneous Squamous Cell Carcinoma
Sponsor:
University of Alabama at Birmingham
Organization:
University of Alabama at Birmingham
Organization Data
Organization:
University of Alabama at Birmingham
Class:
OTHER
Study ID:
F060106002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Alabama at Birmingham
Lead Sponsor Class:
OTHER
Responsible Party:
Eben Rosenthal
Responsible Party Title:
Professor of Surgery - Otolaryngology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Alabama at Birmingham
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| OSI Pharmaceuticals | INDUSTRY |
| Genentech Inc | INDUSTRY |